Evidence map›Paper›PMID 22316070›Full record

ArticleJournal of the American Geriatrics Society2012

Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women.

Susan L Greenspan, Allison Wyman, Frederick H Hooven, Silvano Adami, Stephen Gehlbach, Frederick A Anderson, Steven Boone, Andrea Z Lacroix, Robert Lindsay, J Coen Netelenbos and 4 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of the American Geriatrics Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 2 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Establishing consensus recommendations for long-term osteoporosis care for patients who have attended an Australian fracture liaison service: a Delphi study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2024
    Article
  11. Article
  12. Article
  13. Osteoporosis in 2022: Care gaps to screening and personalised medicine.Best practice & research. Clinical rheumatology · 2022
    Review
  14. Article
  15. Osteoporosis medication after fracture in older adults: an administrative data analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Article
  16. Bone densitometry worldwide: a global survey by the ISCD and IOF.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2020
    Article
  17. Introducing mobile fracture prevention services with DXA in Northern Scotland: a comparative study of three rural communities.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2020
    Article
  18. Review
  19. State of the art in osteoporosis risk assessment and treatment.Journal of endocrinological investigation · 2019
    Review
  20. A population-based study of postfracture care in Manitoba, Canada 2000/2001-2014/2015.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 5 countries.

Susan L GreenspanDepartment of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA. GreenspanS@dom.pitt.edu
Allison Wyman
Frederick H Hooven
Silvano Adami
Stephen Gehlbach
Frederick A Anderson
Steven Boone
Andrea Z Lacroix
Robert Lindsay
J Coen Netelenbos
Johannes Pfeilschifter
Stuart Silverman
Ethel S Siris
Nelson B Watts
University of Massachusetts Chan Medical School · USAlfried Krupp Hospital · DEAmsterdam UMC Location VUmc · NLColumbia University Irving Medical Center · USFred Hutch Cancer Center · USHelen Hayes Hospital · USKU Leuven · BEUniversity of California, Los Angeles · USUniversity of Cincinnati · USUniversity of Pittsburgh · USUniversity of Verona · IT

Funding

VARIABILITY, STABILITY & SMOOTHNESS OF WALKINGP30AG024827 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JENNIFER S BRACH · 2004 to 2026
$28.6M
NIA NIH HHS P30 AG024827
6 · The paper itself

Abstract

objectivesTo determine the proportion of untreated women who reported receiving treatment after incident fracture and to identify factors that predict treatment across an international spectrum of individuals.

designProspective observational study. Self-administered questionnaires were mailed at baseline and 1 year.

settingMultinational cohort of noninstitutionalized women recruited from 723 primary physician practices in 10 countries.

participantsSixty thousand three hundred ninety-three postmenopausal women aged 55 and older were recruited with a 2:1 oversampling of women aged 65 and older. MEASUREMENTS: Data collected included participant demographics, medical history, fracture occurrence, medications, and risk factors for fracture. Anti-osteoporosis medications (AOMs) included estrogen, selective estrogen receptor modulators, bisphosphonates, calcitonin, parathyroid hormone, and strontium.

resultsAfter the first year of follow-up, 1,075 women reported an incident fracture. Of these, 17% had started AOM, including 15% of those with a single fracture and 35% with multiple fractures. Predictors of treatment included baseline calcium use (P = .01), baseline diagnosis of osteoporosis (P < .001), and fracture type (P < .001). In multivariable analysis, women taking calcium supplements at baseline (odds ratio (OR) = 1.67) and with a baseline diagnosis of osteoporosis (OR = 2.55) were more likely to be taking AOM. Hip fracture (OR = 2.61), spine fracture (OR = 6.61), and multiple fractures (OR = 3.79) were associated with AOM treatment. Age, global region, and use of high-risk medications were not associated with treatment.

conclusionMore than 80% of older women with new fractures were not treated, despite the availability of AOM. Important factors associated with treatment in this international cohort included diagnosis of osteoporosis before the incident fracture, spine fracture, and to a lesser degree, hip fracture.

Indexed as

AgedChi-Square DistributionFemaleFollow-Up StudiesFractures, BoneHumansMiddle AgedOsteoporosis, PostmenopausalProspective StudiesRegression AnalysisRisk FactorsSurveys and Questionnaires

Identifiers

PMID22316070
PMCPMC3955945
OpenAlexW2055426452

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.